The relationship between the status of human papillomavirus 16/18 infection and the expression of Bcl-2 and Bax in squamous cell carcinomas of the lung

Chinese Journal of Lung Cancer

Volumn 12, Issue 8, 2009, Pages 849-852

  Xu, Yi ^a   Cheng, Bin ^a   Pan, Huaxiong ^b   Wu, Aijun ^a   Zhang, Li ^a  

^a Second Hospital of WISCO   (China)

^b UNION HOSPITAL   (China)

Author keywords

Bax protein; Bcl 2 protein; Human papillomavirus; In situ hybridization; Lung neoplasms

Indexed keywords

DNA; PROTEIN BAX; PROTEIN BCL 2;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHINA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISOME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG SQUAMOUS CELL CARCINOMA; MORPHOLOGY; PAPILLOMA VIRUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEROLOGY; VIRUS INFECTION;

EID: 69949172014     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.08.03     Document Type: Article

References (13)

1. Syrjänen KJ, Syrjänen SM. Papillomavirus infections in human pathology. New York: J Wiley 85 Sons, 2000.
2. Syrjänen KJ. HPV infections and lung cancer. J Clin Pathol, 2002, 55(12): 885-891.
3. Münger K. The role of human papillomaviruses in human cancers. Front Biosci, 2002, 7: d641-649.
4. Alfandari J, Shnitman Magal S, Jackman A, et al. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology, 1999, 257(2): 383-396. (Pubitemid 29393406)
5. Vernon SD, Unger ER. Molecular characterization of human papillomaviruses by PCR and in situ hybridization. Methods Mol Med, 2004, 97: 159-180.
6. Wang YP, Wang AF, Jiang R, et al Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep, 2008, 20(2): 333-339.
7. Miyagi J, Tsuhako K, Kinjo T, et al. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol, 2000, 53(9): 676-684. (Pubitemid 30692406)
8. Papadopoulou K, Labropoulou V, Davaris P, et al. Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch, 1998, 433(1): 49-54. (Pubitemid 28356476)
9. Cheng YW, Lee H, Shiau MY, et al. Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin Cancer Res, 2008, 14( 15): 4705-4712.
10. Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene, 1999, 18(53): 7690-7700. (Pubitemid 30052696)
11. Yaren A, Oztop I, Kargi A, et al. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Int J Clin Pract, 2006, 60(6): 675-682. (Pubitemid 43811647)
12. Pan HX, Wu CH, Zhou S, et al. Relationship between HPV 16/18 infection and P53 protein expression in lung squamous cell carcinomas. Acta Med Univ Sci Technol Huazhong, 2006, 35(4): 440-443.
13. Magal SS, Jackman A, Ish-Shalom S, et al. Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J Gen Virol, 2005, 86(3): 611-621. (Pubitemid 40331241)